ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GEN Genuit Group Plc

438.00
1.50 (0.34%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Genuit Group Plc GEN ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
1.50 0.34% 438.00 00:35:23
始値 安値 高値 終値 前日終値
431.00 431.00 443.50 438.00 436.50
この銘柄の詳細情報 »
業種
INDUSTRIAL ENGINEERING

最新ニュース

日付 時間 ソース タイトル
2024/4/2418:39UK RNSGenuit Group PLC Notice of AGM
2024/4/1100:24UK RNSGenuit Group PLC Director/PDMR Shareholding
2024/4/1100:17UK RNSGenuit Group PLC Director/PDMR Shareholding
2024/4/1000:28UK RNSGenuit Group PLC Director Declaration
2024/4/0223:56UK RNSGenuit Group PLC Director/PDMR Shareholding
2024/3/2100:27UK RNSGenuit Group PLC Director/PDMR Shareholding
2024/3/1219:40ALNCNewsGenuit revenue drops on lower divisional sales but profit..
2024/3/1216:09ALNCNews*Genuit says 2024 trading has started in line w/..
2024/3/1216:00UK RNSGenuit Group PLC Final Results
2024/3/0117:30UK RNSGenuit Group PLC Director Declaration
2024/2/1918:00UK RNSGenuit Group PLC Notice of Results and Investor Presentation
2024/1/2400:49UKREGGenuit Group PLC Holding(s) in Company
2024/1/2320:24UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
2024/1/2308:40UKREGGenmab A/S Genmab Announces Decision In Arbitration Appeal..
2024/1/0920:45UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental..
2024/1/0314:55UKREGGenmab A/S Transactions With Shares And Linked Securities In..
2024/1/0223:52UKREGGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan..
2023/12/1221:00UKREGGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data..
2023/12/1002:00UKREGGenmab A/S New Pivotal Data For Bispecific Antibody..
2023/12/0607:26UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
2023/11/2721:00UKREGGenmab A/S Genmab Announces Positive Regulatory Updates For..
2023/11/2216:00UKREGGenuit Group PLC Strategy Progress Update Notification
2023/11/2206:45UKREGGenmab A/S Transactions With Shares And Linked Securities In..
2023/11/2206:42UKREGGenmab A/S Grant Of Restricted Stock Units To Board Members..
2023/11/1518:03ALNCNewsGenuit shares rise as annual profit predicted to exceed..
2023/11/1516:00UKREGGenuit Group PLC Trading Update
2023/11/0923:14UKREGGenmab A/S Major Shareholder Announcement
2023/11/0919:08UKREGGenuit Group PLC Director Declaration
2023/11/0919:00UKREGGenmab A/S Genmab To Present At Jefferies London Healthcare..
2023/11/0901:09UKREGGenmab A/S Major Shareholder Announcement
2023/11/0801:01UKREGGenmab A/S Genmab Announces Financial Results For The First..
2023/11/0222:05UKREGGenmab A/S Genmab Announces Multiple Abstracts To Be..
2023/11/0220:59UKREGGenuit Group PLC Director/PDMR Shareholding
2023/11/0201:00UKREGGenuit Group PLC Block listing Interim Review
2023/11/0119:58ALNCNewsIN BRIEF: Genuit confirms interim CFO Tim Pullen as..
2023/11/0116:00UKREGGenuit Group PLC Directorate Change
2023/10/2600:04UKREGGenuit Group PLC Director/PDMR Shareholding
2023/10/2223:30UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Significantly..
2023/10/1800:05UKREGGenuit Group PLC Director/PDMR Shareholding
2023/10/1719:22UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
2023/10/1123:25UKREGGenuit Group PLC Director/PDMR Shareholding
2023/10/0623:59UKREGGenuit Group PLC Director/PDMR Shareholding
2023/9/2903:38UKREGGenmab A/S Grant Of Restricted Stock Units And Warrants To..
2023/9/2520:45UKREGGenmab A/S Genmab Announces European Commission Approval Of..
2023/9/2518:55UKREGGenmab A/S Epkinlytm (epcoritamab) Approved By Japan..
2023/9/1303:04UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
2023/9/1120:56UKREGGenuit Group PLC Director/PDMR Shareholding
2023/9/0504:00UKREGGenmab A/S Genmab And Seagen Announce That Tivdak(R)..
2023/9/0119:19ALNCNewsIN BRIEF: Genuit hires former Arm, IQE exec Tim Pullen as..
2023/9/0118:24DJNGenuit Appoints Tim Pullen as Interim CFO

最近閲覧した銘柄

Delayed Upgrade Clock